Alterity Therapeutics Ltd has released a press release.
Business Update
Filed with ASX ·
On 6ix: 6ix.com/news/business-update-188
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- S&P DJ Indices Announces March Quarterly Review
- S&P DJ Indices Announces March Quarterly Rebalance
- Prana provides regulatory update for PBT2
- Prana announces $4.8 million R&D refund
- New Reach2HD data presented at American Neurological Assoc.
Later from Alterity Therapeutics
- Half Year Accounts
- PBT434 presented at 13th International AD/PD Conference
- PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration
- Prana commences research collaboration with Takeda
- Appendix 4E and Annual Report
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics